| Company Name: |
Bide Pharmatech Ltd.
|
| Tel: |
400-1647117 13681763483 |
| Email: |
product02@bidepharm.com |
| Products Intro: |
Product Name:2-(2-Chlorophenyl)-3-(1-(2,3-dimethylbenzyl)piperidin-4-yl)-5-fluoro-1H-indole
CAS:1199797-92-6
Purity:98% Package:5mg;10mg;25mg;50mg;100mg Remarks:BD02293330
|
CDFI manufacturers
- CDFI
-
- $143.00
-
2026-04-22
- CAS:1199797-92-6
- Purity: 99.86%
- Supply Ability: 10g
- CDFI
-
-
2025-03-16
- CAS:1199797-92-6
- Min. Order: 1MG
- Purity: 98
- Supply Ability: 10G
|
| Product Name: | CDFI | | Synonyms: | CDFI;1H-Indole, 2-(2-chlorophenyl)-3-[1-[(2,3-dimethylphenyl)methyl]-4-piperidinyl]-5-fluoro-;2-(2-Chlorophenyl)-3-(1-(2,3-dimethylbenzyl)piperidin-4-yl)-5-fluoro-1H-indole | | CAS: | 1199797-92-6 | | MF: | C28H28ClFN2 | | MW: | 446.99 | | EINECS: | | | Product Categories: | | | Mol File: | 1199797-92-6.mol |  |
| Boiling point | 589.923±50.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.220±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | form | Solid | | pka | 15.391±0.30(predicted) | | color | White to light yellow |
| Uses | CDFI is an inhibitor of the lipid II flippase MurJ. CDFI potentiates the activity of β-lactams against MRSA[1][2]. | | References | [1] Fernandes PB, et al. Revisiting the Role of VraTSR in Staphylococcus aureus Response to Cell Wall-Targeting Antibiotics. J Bacteriol. 2022 Aug 16;204(8):e0016222. DOI:10.1128/jb.00162-22
[2] Dhanda G, et al. Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance. ACS Omega. 2023 Mar 14;8(12):10757-10783. DOI:10.1021/acsomega.3c00312 |
| | CDFI Preparation Products And Raw materials |
|